Rapport: Rutinebrug af CYP-test ved antipsykotisk behandling

27. Ellingrod VL, Schultz SK, Arndt S. Abnormal movements and tardive dyskinesiain smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.Pharmacotherapy 2002 11;22(11):1416-1419.28. Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, et al. Association of CYP2D6and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenicpatients. Acta Pharmacol Sin 2006 03;27(3):328-332.29. Inada T, Senoo H, Iijima Y, Yamauchi T, Yagi G. Cytochrome P450 II D6 genepolymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japaneseschizophrenic patients. Psychiatr Genet 2003 09;13(3):163-168.30. Jaanson P, Marandi T, Kiivet RA, Vasar V, Vaan S, Svensson JO, et al. Maintenancetherapy with zuclopenthixol decanoate: associations between plasma concentrations,neurological side effects and CYP2D6 genotype. Psychopharmacology (Berl) 200206;162(1):67-73.31. Kapitany T, Meszaros K, Lenzinger E, Schindler SD, Barnas C, Fuchs K, et al.Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia inschizophrenia. Schizophr Res 1998 07/27;32(2):101-106.32. Lam LC, Garcia-Barcelo MM, Ungvari GS, Tang WK, Lam VK, Kwong SL, et al.Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chineseschizophrenic patients. Pharmacopsychiatry 2001 11;34(6):238-241.33. Liou YJ, Wang YC, Bai YM, Lin CC, Yu SC, Liao DL, et al. Cytochrome P-4502D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardivedyskinesia in Chinese schizophrenic patients. Neuropsychobiology2004;49(4):167-173.34. Lohmann PL, Bagli M, Krauss H, Muller DJ, Schulze TG, Fangerau H, et al.CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.Pharmacopsychiatry 2003 03;36(2):73-78.35. Nikoloff D, Shim JC, Fairchild M, Patten N, Fijal BA, Koch WH, et al.Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics.Pharmacogenomics J 2002;2(1470-269; 1470-269; 6):400-407.36. Ohmori O, Suzuki T, Kojima H, Shinkai T, Terao T, Mita T, et al. Tardive dyskinesiaand debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics.Schizophr Res 1998 07/27;32(2):107-113.37. Ohmori O, Kojima H, Shinkai T, Terao T, Suzuki T, Abe K. Genetic associationanalysis between CYP2D6*2 allele and tardive dyskinesia in schizophrenic patients.Psychiatry Res 1999 10/11;87(2-3):239-244.38. Plesnicar BK, Zalar B, Breskvar K, Dolzan V. The influence of the CYP2D6 polymorphismon psychopathological and extrapyramidal symptoms in the patients onlong-term antipsychotic treatment. J Psychopharmacol 2006 11;20(6):829-833.90 Rutinebrug af CYP-test ved antipsykotisk behandling